USPTO Patents Application 09589288

ticwLi vi ii w nwivi luvvicuyci i ici 1 i ncwci |J i

EFSID:

5219321

Application Number:

09589288

International Application Number:

Confirmation Number:

1519

Title of Invention:

METHODS OF INHIBITING B LYMPHOCYTES USING ANTIBODIES TO
NEUTROKINE-ALPHA

First Named Inventor/Applicant Name:

Guo-Liang Yu

Customer Number:

73326

Filer:

John Jr. Kilyk/Himanshu Thakur

Filer Authorized By:

John Jr. Kilyk

Attorney Docket Number:

PF343P3C5

Receipt Date:

24-APR-2009

Filing Date:

08-JUN-2000

Time Stamp:

21:39:57

Application Type:

Utility under 35 USC 111(a)

Payment information:

Submitted with Payment

no

File Listing:

Document
Number

Document Description

File Name

FileSize(Bytes)/
Message Digest

Multi
Part /.zip

Pages
(ifappl.)

1

NPL Documents

DeclarationCash-

1400122

no

17

EP_0939804-2008.pdf

Warnings:

Information:

2

NPL Documents

DeclarationNoelle-
EP_0939804-2008.pdf

390897

44

Warnings:

Information:

3

NPL Documents

DeclarationFarrow-
EP_0939804-2008.pdf

1029735

31

Warnings:

Information:

4

NPL Documents

WitnessStatementPennacchio-
EP_0939804-2008.pdf

2127416

41

Warnings:

Information:

5

NPL Documents

ListofDocuments-
EP_0939804-2008.pdf

54546

5

Warnings:

Information:

6

NPL Documents

HGSOpposition-
EP_1146892-2004-1.pdf

1417187

34

Warnings:

Information:

7

NPL Documents

HGSOpposition-
EP_1146892-2004-2.pdf

18511734

370

Warnings:

Information:

8

NPL Documents

SeronoOpposition-
EP_1146892-2004.pdf

1149734

29

Warnings:

Information:

9

NPL Documents

ZymogeneticsResponseOpposi
tions-EP_1 141274-2005.pdf

6658749

159

Warnings:

Information:

10

NPL Documents

HGSReplyZymogeneticsRespon
se-EP_1141274-2005.pdf

1418461

36

Warnings:

Information:

11

NPL Documents

OppositionDivisionPreliminary
Opinion-EP_1 1 41 274-2007.pdf

1042109

24

Warnings:

Information:

12

NPL Documents

SecondDeclarationMartinHGS-
EP_0939804-2008.pdf

104718

15

Warnings:

Information:

13

NPL Documents

DeclarationGilbertHGS-
EP_0939804-2008.pdf

75287

5

Warnings:

Information:

14

NPL Documents

HGSPressRelease-1 2-01 -1 999.
pdf

206199

3

Warnings:

Information:

15

NPL Documents

TranscriptDepositionNoelle-
INT_1 05485-2007.pdf

11439806

309

Warnings:

Information:

16

NPL Documents

DeclarationOlsen-
INT_1 05485-2007.pdf

113280

4

Warnings:

Information:

17

NPL Documents

BrowningOppositionTableofCo
ntent-INT_1 05485-2007-1 .pdf

135162

42

Warnings:

Information:

18

NPL Documents

BrowningOppositionTableofCo
ntent-INT_1 05485-2007-2.pdf

19150

1

Warnings:

Information:

19

NPL Documents

YuExhibitl 200DepositionBouff
ard-INT_1 05485-2008.pdf

290971

17

Warnings:

Information:

20

NPL Documents

DeclarationKelsoe-
EP_0939804-2009.pdf

142571

17

Warnings:

Information:

21

NPL Documents

YuExhibitl 201 DepositionBouff
ard-INT_1 05485-2008.pdf

184617

8

Warnings:

Information:

22

NPL Documents

TranscriptTeleconference-
INT_1 05485-2008.pdf

994391

24

Warnings:

Information:

23

NPL Documents

ClaimFormLilly-
EP_0939804-2006.pdf

92756

2

Warnings:

Information:

24

NPL Documents

HGSDefenseEP 0939804-2006.
pdf

21158

1

Warnings:

Information:

25

NPL Documents

HGSPatentlnSuit-HC06CO2687.
pdf

2590643

57

Warnings:

Information:

26

NPL Documents

ApplicationAmendClaimsHGS-
HC06CO2687-2007.pdf

297739

11

Warnings:

Information:

27

NPL Documents

AgreedStatementofFactslMAG
EEST-HC06CO2687.pdf

15683

1

Warnings:

Information:

28

NPL Documents

ApprovedJudgmentJusticeKitc
hin-HC06CO2687-2008.pdf

5341467

86

Warnings:

Information:

29

NPL Documents

QuotationsOnTheClosestPriorA
rt.pdf

98748

3

Warnings:

Information:

30

NPL Documents

DeclarationLoExhibitsAtoL-
EP_1294769-2008.pdf

7699356

92

Warnings:

Information:

31

NPL Documents

MinutesOralProceedingsOppos
itionDivisionDecisionRevoking-
EP_0939804-2008.pdf

2440287

47

Warnings:

Information:

32

NPL Documents

HGSPressRelease-
HGSReportsResultsPhase2Clini
calTrialLymphostatBRheumatoi

dArthritis-2005.pdf

56595

4

Warnings:

Information:

33

NPL Documents

HGSPressRelease-
HGSAnnouncesPositive76Week
ResultsPhase2ClinicalTrialLymp
hostatBSLE-2006.pdf

88739

4

Warnings:

Information:

34

NPL Documents

HGSPressRelease-
HGSGSKInitiateSecondPhase3C
NnicalTrialLymphostatB-2007.
pdf

77377

3

Warnings:

Information:

35

NPL Documents

ShuAlignmentOverlayGrussDo
wer.pdf

585341

1

Warnings:

Information:

36

NPL Documents

SchneiderAlignmentOverlayGr
ussDower.pdf

626182

1

Warnings:

Information:

37

NPL Documents

PF620-OA-1st.pdf

378661

10

Warnings:

Information:

1897148

38

NPL Documents

PF620-OA-2nd.pdf

30

Warnings:

Information:

3001 1 1

39

NPL Documents

PF620-OA-3rd.pdf

9

Warnings:

Information:

40

NPL Documents

Partial!" ranscriptEnglishCostsH

18274

3

Warnings:

Information:

337968

41

NPL Documents

PF529-OA-1st.pdf

6

Warnings:

Information:

977835

42

NPL Documents

PF529-OA-2nd.pdf

23

Warnings:

Information:

507838

43

NPL Documents

PF529-OA-3rd.pdf

13

Warnings:

Information:

370540

44

NPL Documents

PF529C1-OA-1st.pdf

10

Warnings:

Information:

809343

45

NPL Documents

PF529C1-OA-2nd.pdf

20

Warnings:

Information:

479129

46

NPL Documents

PF523P1-OA-1st.pdf

13

Warnings:

Information:

47

NPL Documents

PF523P1-OA-2nd.pdf

679131

17

Warnings:

Information:

48

NPL Documents

PF523P1-OA-3rd.pdf

543959

13

Warnings:

Information:

49

NPL Documents

PF523P1-INT-SUMMARY-1st.pdf

149934

3

Warnings:

Information:

50

NPL Documents

PF523P1-AA-1st.pdf

707302

16

Warnings:

Information:

51

NPL Documents

PF523P2-OA-1st.pdf

252300

7

Warnings:

Information:

52

NPL Documents

PF523P2-OA-2nd.pdf

613489

14

Warnings:

Information:

53

NPL Documents

PF523P3-OA-1st.pdf

269232

7

Warnings:

Information:

54

NPL Documents

PF523P3-OA-2nd.pdf

202905

6

Warnings:

Information:

55

NPL Documents

PF523P3-OA-3rd.pdf

532930

13

Warnings:

Information:

56

NPL Documents

PF523P3-OA-4th.pdf

295685

«c MWd9 7 9 e04«3»aca7a 9 3 66 a0

7

Warnings:

Information:

57

NPL Documents

PF523P1D1-AA-1st.pdf

111710

3

Warnings:

Information:

58

NPL Documents

PF523P1D1-OA-1st.pdf

286057

7

Warnings:

Information:

59

NPL Documents

PF523P1D1-OA-2nd.pdf

480815

13

Warnings:

Information:

60

NPL Documents

PF523P1D1-OA-3rd.pdf

26081 1

7

Warnings:

Information:

Total Files Size (in bytes)

80402020

This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
Post Card, as described in MPEP 503.

New Applications Under 35 U.S.C. 1 1 1

If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
1 .53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1 .54) will be issued in due course and the date shown on this
Acknowledgement Receipt will establish the filing date of the application.

National Stage of an International Application under 35 U.S.C. 371

If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.

New International Application Filed with the USPTO as a Receiving Office

If a new international application is being filed and the international application includes the necessary components for
an international filing date (see PCT Article 1 1 and MPEP 1 81 0), a Notification of the International Application Number
and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
the application.